真爱美家：10月24日召开董事会会议

Group 1 - The core point of the article is that Zhenai Meijia (SZ 003041) held its 15th meeting of the fourth board on October 24, 2025, to review the proposal for the company's Q3 2025 report [1] - For the first half of 2025, Zhenai Meijia's revenue composition is entirely from the textile industry, accounting for 100.0% [1] - As of the report date, Zhenai Meijia has a market capitalization of 4.1 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine, while the primary market is facing fundraising challenges [1]